U.S. Military Announces Testosterone Level Testing and Replacement Therapy for Service Members
The U.S. military plans to test service members' testosterone levels and provide replacement therapy where appropriate, following an announcement by Defense Secretary Pete Hegseth. This move aligns with a broader Trump administration initiative promoting public access to such therapies, which are produced by companies like AbbVie (ABBV), Pfizer (PFE), and Marius Pharmaceuticals.
Topics: men's health public health testosterone replacement therapy U.S. military policy